Ajanta Pharma
Mr. Rajesh Agrawal is the Jt. Managing Director of Ajanta Pharma. A graduate in Business Studies from University of Buckingham, UK and MBA from Bentley College, USA, he joined the company in 1999. It is under his joint leadership that the company made a corporate turnaround and emerged as a leading specialty focused company. He has transformed Ajanta's domestic business to one of the best performing market for the company. His keen focus on new products and strategizing has made Ajanta a leading player in the segments of cardiology, dermatology and ophthalmology in a very short period. Most of the new product launches, being first of its kind in the Indian market are credited to his business acumen. He has also replicated this success in the Philippines, where the Ajanta Pharma Philippines features amongst the fastest growing companies in that country for over three years.
This person is not in any offices
Ajanta Pharma
2 followers
Ajanta Pharma Limited is a holding company. The Company is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations. Its business includes branded generics in emerging markets of Asia and Africa, generics in the developed markets of the United States and Institutional sales. The branded generics business is spread in India and over 30 emerging countries across Africa, Commonwealth of Independent States (CIS), the Middle East and South East Asia. The Company serves a range of therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, orthopedics, pediatric, respiratory and general health products. Ajanta has six formulations manufacturing facilities located in India and 1 in Mauritius. In addition, the Company also has an API manufacturing facility located at Waluj, India. The Company's subsidiaries include Ajanta Pharma (Mauritius) Ltd., and Ajanta Pharma USA Inc.